Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates

Jennifer Reinboth, Maria L. Ascierto, Nanhai G. Chen, Qian Zhang, Yong A. Yu, Richard J. Aguilar, Rafael Carretero, Andrea Worschech, Yingdong Zhao, Ena Wang, Francesco M. Marincola, Aladar A. Szalay

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Vaccinia virus (VACV) has emerged as an attractive tool in oncolytic virotherapy. VACV replication efficiency plays a crucial role in the therapeutic outcome. However, little is known about the influence of host factors on viral replication efficiency and permissiveness of a host cell line to infection and oncolysis. In this study, replication of the attenuated VACV GLV-1h68 strain and three wild-type VACV isolates was determined in two autologous human melanoma cell lines (888-MEL and 1936-MEL). Host gene expression and viral gene expression in infected cells were evaluated via respective expression array platforms. Microarray analyses followed by sequential statistical approaches characterized human genes that change specifically due to virus infection. Viral gene transcription correlated with viral replication in a time-dependent manner. A set of human genes revealed strong correlations with the respective viral gene expression. Finally we identified a set of human genes with possible predictive value for viral replication in an independent dataset. The results demonstrate a probable correlation between viral replication, early gene expression, and the respective host response, and thus a possible involvement of human host factors in viral early replication. The characterization of human target genes that influence viral replication could help answer the question of host cell permissiveness to oncolytic virotherapy and provide important information for the development of novel recombinant vaccinia viruses with improved features to enhance replication rate and hence trigger therapeutic outcome.

Original languageEnglish
Pages (from-to)285-296
Number of pages12
JournalHuman gene therapy methods
Volume23
Issue number5
DOIs
Publication statusPublished - 1 Oct 2012
Externally publishedYes

Fingerprint

Oncolytic Viruses
Vaccinia virus
Viral Genes
Oncolytic Virotherapy
Permissiveness
Gene Expression
Genes
Cell Line
Virus Diseases
Microarray Analysis
Virus Replication
Melanoma
Therapeutics
Infection

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Molecular Medicine
  • Genetics
  • Pharmacology
  • Genetics(clinical)

Cite this

Reinboth, J., Ascierto, M. L., Chen, N. G., Zhang, Q., Yu, Y. A., Aguilar, R. J., ... Szalay, A. A. (2012). Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates. Human gene therapy methods, 23(5), 285-296. https://doi.org/10.1089/hgtb.2012.057

Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates. / Reinboth, Jennifer; Ascierto, Maria L.; Chen, Nanhai G.; Zhang, Qian; Yu, Yong A.; Aguilar, Richard J.; Carretero, Rafael; Worschech, Andrea; Zhao, Yingdong; Wang, Ena; Marincola, Francesco M.; Szalay, Aladar A.

In: Human gene therapy methods, Vol. 23, No. 5, 01.10.2012, p. 285-296.

Research output: Contribution to journalArticle

Reinboth, J, Ascierto, ML, Chen, NG, Zhang, Q, Yu, YA, Aguilar, RJ, Carretero, R, Worschech, A, Zhao, Y, Wang, E, Marincola, FM & Szalay, AA 2012, 'Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates', Human gene therapy methods, vol. 23, no. 5, pp. 285-296. https://doi.org/10.1089/hgtb.2012.057
Reinboth, Jennifer ; Ascierto, Maria L. ; Chen, Nanhai G. ; Zhang, Qian ; Yu, Yong A. ; Aguilar, Richard J. ; Carretero, Rafael ; Worschech, Andrea ; Zhao, Yingdong ; Wang, Ena ; Marincola, Francesco M. ; Szalay, Aladar A. / Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates. In: Human gene therapy methods. 2012 ; Vol. 23, No. 5. pp. 285-296.
@article{c174185d36994884a81177b4b0cde780,
title = "Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates",
abstract = "Vaccinia virus (VACV) has emerged as an attractive tool in oncolytic virotherapy. VACV replication efficiency plays a crucial role in the therapeutic outcome. However, little is known about the influence of host factors on viral replication efficiency and permissiveness of a host cell line to infection and oncolysis. In this study, replication of the attenuated VACV GLV-1h68 strain and three wild-type VACV isolates was determined in two autologous human melanoma cell lines (888-MEL and 1936-MEL). Host gene expression and viral gene expression in infected cells were evaluated via respective expression array platforms. Microarray analyses followed by sequential statistical approaches characterized human genes that change specifically due to virus infection. Viral gene transcription correlated with viral replication in a time-dependent manner. A set of human genes revealed strong correlations with the respective viral gene expression. Finally we identified a set of human genes with possible predictive value for viral replication in an independent dataset. The results demonstrate a probable correlation between viral replication, early gene expression, and the respective host response, and thus a possible involvement of human host factors in viral early replication. The characterization of human target genes that influence viral replication could help answer the question of host cell permissiveness to oncolytic virotherapy and provide important information for the development of novel recombinant vaccinia viruses with improved features to enhance replication rate and hence trigger therapeutic outcome.",
author = "Jennifer Reinboth and Ascierto, {Maria L.} and Chen, {Nanhai G.} and Qian Zhang and Yu, {Yong A.} and Aguilar, {Richard J.} and Rafael Carretero and Andrea Worschech and Yingdong Zhao and Ena Wang and Marincola, {Francesco M.} and Szalay, {Aladar A.}",
year = "2012",
month = "10",
day = "1",
doi = "10.1089/hgtb.2012.057",
language = "English",
volume = "23",
pages = "285--296",
journal = "Human gene therapy methods",
issn = "1946-6536",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates

AU - Reinboth, Jennifer

AU - Ascierto, Maria L.

AU - Chen, Nanhai G.

AU - Zhang, Qian

AU - Yu, Yong A.

AU - Aguilar, Richard J.

AU - Carretero, Rafael

AU - Worschech, Andrea

AU - Zhao, Yingdong

AU - Wang, Ena

AU - Marincola, Francesco M.

AU - Szalay, Aladar A.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Vaccinia virus (VACV) has emerged as an attractive tool in oncolytic virotherapy. VACV replication efficiency plays a crucial role in the therapeutic outcome. However, little is known about the influence of host factors on viral replication efficiency and permissiveness of a host cell line to infection and oncolysis. In this study, replication of the attenuated VACV GLV-1h68 strain and three wild-type VACV isolates was determined in two autologous human melanoma cell lines (888-MEL and 1936-MEL). Host gene expression and viral gene expression in infected cells were evaluated via respective expression array platforms. Microarray analyses followed by sequential statistical approaches characterized human genes that change specifically due to virus infection. Viral gene transcription correlated with viral replication in a time-dependent manner. A set of human genes revealed strong correlations with the respective viral gene expression. Finally we identified a set of human genes with possible predictive value for viral replication in an independent dataset. The results demonstrate a probable correlation between viral replication, early gene expression, and the respective host response, and thus a possible involvement of human host factors in viral early replication. The characterization of human target genes that influence viral replication could help answer the question of host cell permissiveness to oncolytic virotherapy and provide important information for the development of novel recombinant vaccinia viruses with improved features to enhance replication rate and hence trigger therapeutic outcome.

AB - Vaccinia virus (VACV) has emerged as an attractive tool in oncolytic virotherapy. VACV replication efficiency plays a crucial role in the therapeutic outcome. However, little is known about the influence of host factors on viral replication efficiency and permissiveness of a host cell line to infection and oncolysis. In this study, replication of the attenuated VACV GLV-1h68 strain and three wild-type VACV isolates was determined in two autologous human melanoma cell lines (888-MEL and 1936-MEL). Host gene expression and viral gene expression in infected cells were evaluated via respective expression array platforms. Microarray analyses followed by sequential statistical approaches characterized human genes that change specifically due to virus infection. Viral gene transcription correlated with viral replication in a time-dependent manner. A set of human genes revealed strong correlations with the respective viral gene expression. Finally we identified a set of human genes with possible predictive value for viral replication in an independent dataset. The results demonstrate a probable correlation between viral replication, early gene expression, and the respective host response, and thus a possible involvement of human host factors in viral early replication. The characterization of human target genes that influence viral replication could help answer the question of host cell permissiveness to oncolytic virotherapy and provide important information for the development of novel recombinant vaccinia viruses with improved features to enhance replication rate and hence trigger therapeutic outcome.

UR - http://www.scopus.com/inward/record.url?scp=84878746275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878746275&partnerID=8YFLogxK

U2 - 10.1089/hgtb.2012.057

DO - 10.1089/hgtb.2012.057

M3 - Article

VL - 23

SP - 285

EP - 296

JO - Human gene therapy methods

JF - Human gene therapy methods

SN - 1946-6536

IS - 5

ER -